Structurally modified analogues of glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) as future antidiabetic agents.


Autoria(s): Green, Brian
Data(s)

2004

Identificador

http://pure.qub.ac.uk/portal/en/publications/structurally-modified-analogues-of-glucagonlike-peptide1-glp1-and-glucosedependent-insulinotropic-polypeptide-gip-as-future-antidiabetic-agents(abac573c-6067-4722-84e4-99fbc996795f).html

http://www.scopus.com/inward/record.url?scp=6344241190&partnerID=8YFLogxK

Idioma(s)

eng

Direitos

info:eu-repo/semantics/restrictedAccess

Fonte

Green , B 2004 , ' Structurally modified analogues of glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) as future antidiabetic agents. ' Current Pharmaceutical Design , vol 10(29) , no. 29 , pp. 3651-3662 .

Palavras-Chave #/dk/atira/pure/subjectarea/asjc/1300/1313 #Molecular Medicine #/dk/atira/pure/subjectarea/asjc/3000 #Pharmacology, Toxicology and Pharmaceutics(all)
Tipo

article